Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Melissa Liet Hing Ng"'
Autor:
Tara Cochrane, Jessica Pearce, Constantine S. Tam, Sumi Ratnasingam, Lourdes Calvente, Chan Yoon Cheah, Anna M. Johnston, Roopesh Kansara, Diego Villa, Stephen Bell, Maher K. Gandhi, Joshua W.D. Tobin, Michael MacManus, Eliza A Hawkes, David C. Hodgson, Melissa Liet Hing Ng, James Gallo, Emad Uddin Abro, Georgina Hodges, Jonathan Wong, Peter Mollee, Dipti Talaulikar, Robert Kridel, Nicholas Matigian, Kirk Morris, Katherine Colvin, Robert N Campbell, Chengetai Dunduru, Erica S Tsang, Sophie Shorten, Wojt Janowski, Kerry J. Savage, Xuan Tan, Michael Gilbertson, Gabrielle Rule, Greg Hapgood, Shao Yang Tneh
Publikováno v:
Blood Advances. 3:2804-2811
Management practices in early-stage (I/II) follicular lymphoma (FL) are variable and include radiation (RT), systemic therapy, or combined modality therapy (CMT). There is a paucity of data regarding maintenance rituximab in this cohort. We conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469b769e3fb54257b8cb49aa0b5fad3b
https://doi.org/10.1182/bloodadvances.2019000458
https://doi.org/10.1182/bloodadvances.2019000458
Autor:
John F. Seymour, Niles Nelson, Tara Cochrane, Chan Yoon Cheah, Sanjay De Mel Widanalage, Hui Peng Lee, Melissa Liet Hing Ng, Eliza A Hawkes, Greg Hapgood, Anna Johnston, Sophie Shorten, Sumita Ratnasingam, Liu Xin, Robert M. Campbell, Constantine S. Tam, Kate Manos, Tenny Sunny, Michelle Poon, David Ritchie, Anthony P. Schwarer, Duncan Purtill, Mark Bishton, Stephen Opat, Zi Yun Ng, Kate Hill, Michael Gilbertson
Publikováno v:
Hematological oncologyREFERENCES. 37(3)
Mantle cell lymphoma (MCL) is an uncommon and typically aggressive form of lymphoma. Although often initially chemosensitive, relapse is common. Several induction and conditioning regimens are used in transplant-eligible patients, and the optimal app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3fb120e2058a8c65e0f902b02bbb8a
https://pubmed.ncbi.nlm.nih.gov/30983008
https://pubmed.ncbi.nlm.nih.gov/30983008
Autor:
Roopesh Kansara, Jessica Pearce, Constantine S. Tam, Melissa Liet Hing Ng, Jonathan Wong, Eliza A Hawkes, Diego Villa, Emad Uddin Abro, Dipti Talaulikar, Sophie Shorten, Chan Yoon Cheah, Jacob Darch, Lourdes Calvente, Xuan Tan, Anna Johnson, Michael Gilbertson, Greg Hapgood, James Gallo, Sumita Ratnasingam, Kerry J. Savage, Robert M. Campbell, Stephen Bell, Tara Cochrane, Shao Yang Tneh, David C. Hodgson, Gabrielle Rule, Georgina Hodges, Wojt Janowski, Robert Kridel, Katherine Colvin, Chengetai Dunduru, Joshua W.D. Tobin, Erica S Tsang, Maher K. Gandhi, Kirk Morris
Publikováno v:
Blood. 132:4148-4148
Background Stage I/II or early-stage follicular lymphoma (ESFL) is considered potentially curable with radiotherapy (XRT). While XRT does achieve local disease control in >90% of cases, more than half the patients (pts) relapse by 10 years (yr), gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b847df09a524c351c7bcda3813a55013
https://doi.org/10.1182/blood-2018-99-114097
https://doi.org/10.1182/blood-2018-99-114097